Publikationen von Ulrike Schmidt

Rosner, R.; Koenig, H.-H.; Neuner, F.; Schmidt, U.; Steil, R.: Developmentally adapted cognitive processing therapy for adolescents and young adults with PTSD symptoms after physical and sexual abuse: study [Study Protocol] protocol for a randomized controlled trial. TRIALS 15, 195 (2014)

Albu, S.; Romanowski, C. P. N.; Curzi, M. L.; Jakubcakova, V.; Flachskamm, C.; Gassen, N. C.; Hartmann, J.; Schmidt, M. V.; Schmidt, U.; Rein, T. et al.; Holsboer, F.; Hausch, F.; Paez-Pareda, M.; Kimura, M.: Deficiency of FK506-binding protein ( FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice. JOURNAL OF SLEEP RESEARCH 23 (2), S. 176 - 185 (2014)

Dine, J.; Ionescu, I. A.; Stepan, J.; Yen, Y.-C.; Holsboer, F.; Landgraf, R.; Eder, M.; Schmidt, U.: Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis. PLOS ONE 8 (3), e60219 (2013)

Schmidt, U.; Kaltwasser, S. F.; Wotjak, C. T.: Biomarkers in Posttraumatic Stress Disorder: Overview and Implications for Future Research. DISEASE MARKERS 35 (1), S. 43 - 54 (2013)

Ionescu, I. A.; Dine, J.; Yen, Y. C.; Buell, D. R.; Herrmann, L.; Holsboer, F.; Eder, M.; Landgraf, R.; Schmidt, U.: Intranasally Administered Neuropeptide S (NPS) Exerts Anxiolytic Effects Following Internalization Into NPS Receptor-Expressing Neurons. Neuropsychopharmacology 37 (6), S. 1323 - 1337 (2012)

Hartmann, J.; Wagner, K. V.; Liebl, C.; Scharf, S. H.; Wang, X. D.; Wolf, M.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C. et al.; Cheung-Flynn, J.; Cox, M. B.; Smith, D. F.; Holsboer, F.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 62 (1), S. 332 - 339 (2012)

Knapp, R. T.; Steiner, A.; Schmidt, U.; Hafner, K.; Holsboer, F.; Rein, T.: BAG-1 diversely affects steroid receptor activity. Biochemical Journal 441, S. 297 - 303 (2012)

Touma, C.; Gassen, N. C.; Herrmann, L.; Cheung-Flynn, J.; Büll, D. R.; Ionescu, I. A.; Heinzmann, J. M.; Knapman, A.; Siebertz, A.; Depping, A. M. et al.; Hartmann, J.; Hausch, F.; Schmidt, M. V.; Holsboer, F.; Ising, M.; Cox, M. B.; Schmidt, U.; Rein, T.: FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior. Biological Psychiatry 70 (10), S. 928 - 936 (2011)

Büll, D.; Sato, M.; Burgmair, W.; Bettecken, T.; Weber, M.; Rein, T.; Uhr, M.; Schmidt, U.: Searching for biomarkers in a historic sample of Amyotrophic Lateral Sclerosis - The Munich Historic Brain Bank Project. Pharmacopsychiatry 44 (6), S. 284 - 284 (2011)

Czibere, L.; Brehm, N.; Naik, R.; Herrmann, L.; Schmidt, U.; Landgraf, R.: Functional characterization of single-nucleotide polymorphisms in the HAB/LAB mouse Tmem132d promoter. Pharmacopsychiatry 44 (6), S. 287 - 287 (2011)

Hartmann, J.; Wagner, K. V.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology 21 (Suppl. 3), S. S189 - S190 (2011)

Hartmann, J.; Wagner, K. V.; Liebl, C.; Wolf, M.; Scharf, S. H.; Wang, X. D.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C. et al.; Müller, M. B.; Schmidt, M. V.: The involvement of FKBP51 and FKBP52 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 44 (6), S. 294 - 294 (2011)

Herrmann, L.; Golub, Y.; Henes, K.; Ionescu, I.; Büll, D.; Holsboer, F.; Wotjak, C. W.; Schmidt, U.: Decreased expression of synaptic proteins in a mouse model of posttraumatic stress disorder. Pharmacopsychiatry 44 (6), S. 295 - 295 (2011)

Hartmann, J.; Wagner, K. V.; Hausch, F.; Rein, T.; Schmidt, U.; Touma, C.; Müller, M. B.; Schmidt, M. V.: The involvement of FK506-binding protein 51 gene (FKBP51) in the behavioural and neuroendocrine effects of acute and chronic stress. European Neuropsychopharmacology 21 (Suppl. 1), S. S8 - S9 (2011)

Golub, J.; Kaltwasser, S. F.; Mauch, C. P.; Herrmann, L.; Schmidt, U.; Holsboer, F.; Czisch, M.; Wotjak, C. T.: Reduced hippocampus volume in the mouse model of Posttraumatic Stress Disorder. Journal of Psychciatric Research 45 (5), S. 650 - 659 (2011)

Schmidt, U.; Holsboer, F.; Rein, T.: Epigenetic aspects of posttraumatic stress disorder. Disease Markers 30 (2-3), S. 77 - 87 (2011)

Schmidt, U.: Die Posttraumatische Belastungsstörung - ein Resultat dysfunktionaler epigenetischer Adaptionsprozesse? Psychotherapie 15 (2), S. 223 - 231 (2010)

Schmidt, U.; Gall-Kleebach, D.: Besonderheiten der Traumpsychotherapie von Soldaten und Kriegsveteranen - Ein Erfahrungsbericht. Psychotherapie 15 (2), S. 317 - 321 (2010)

Christian, L.; Golub, Y.; Rein, T.; Wotjak, C. T.; Schmidt, U.: Biomarkers in a mouse model of posttraumatic stress disorder. Pharmacopsychiatry 42 (5), S. 214 - 214 (2009)

Hartmann, J.; Wagner, K.; Liebl, C.; Wolf, M.; Scharf, S.; Wang, X. D.; Harbich, D.; Mayer, B.; Rein, T.; Schmidt, U. et al.; Hausch, F.; Smith, D.; Cox, M. B.; Müller, M. B.; Schmidt, M. V.: The involvement of FKBP5 in the behavioural and neuroendocrine effects of acute and chronic stress. Pharmacopsychiatry 42 (5), S. 221 - 221 (2009)